Literature DB >> 11684978

Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques.

V Casati1, C Gerli, A Franco, P Della Valle, S Benussi, O Alfieri, G Torri, A D'Angelo.   

Abstract

BACKGROUND: The authors studied the changes in selected hemostatic variables in patients undergoing coronary surgery with on-pump coronary artery bypass grafting (CABG) or off-pump coronary artery bypass surgery (OPCAB) techniques.
METHODS: Platelet counts and plasma concentrations of antithrombin, fibrinogen, D dimer, alpha(2) antiplasmin, and plasminogen were measured preoperatively, 5 min after administration of heparin, 10 min after arrival in the intensive care unit, and 24 h after surgery in patients scheduled to undergo OPCAB (n = 15) or CABG (n = 15). To correct for dilution, hemostatic variables and platelet counts were adjusted for the changes in immunoglobulin G plasma concentrations and hematocrit, respectively.
RESULTS: Adjusting for dilution, antithrombin and fibrinogen concentrations decreased to a similar extent in patients undergoing OPCAB or CABG (pooled means and 95% confidence limits of the mean: 95.5% of baseline, 93-98%, P = 0.002, and 91.7% of baseline, 88-95%, P = 0.0001), respectively, whereas alpha(2)-antiplasmin concentrations were unchanged. Only CABG was associated with a reduction in platelet counts (76% of baseline, 66-85%, P = 0.0001), plasminogen concentrations (96% of baseline, 91-99%, P = 0.011), and increased D-dimer formation (476%, 309-741%, P = 0.004). Twenty-four hours after surgery, platelet counts were still lower in patients undergoing CABG (P = 0.049), but all the investigated variables adjusted for dilution were similar in the two groups.
CONCLUSIONS: Coronary surgery causes a net consumption of antithrombin and fibrinogen. A transient decrease in platelet counts, with plasminogen activation and increased D-dimer formation, however, is only observed with CABG. Twenty-four hours after surgery, the hemostatic profiles of patients in both groups are similar.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684978     DOI: 10.1097/00000542-200111000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  16 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

Review 2.  Pump or no pump for coronary artery bypass: current best available evidence.

Authors:  Shahzad G Raja
Journal:  Tex Heart Inst J       Date:  2005

Review 3.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

4.  Platelet hyperreactivity in response to on- and off-pump coronary artery bypass grafting.

Authors:  Louise Bochsen; Lisbeth Bredahl Rosengaard; Allan Bybeck Nielsen; Daniel A Steinbrüchel; Pär I Johansson
Journal:  J Extra Corpor Technol       Date:  2009-03

5.  Anticoagulant therapy during cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

6.  Changes in activated partial thromboplastin time and international normalised ratio after on-pump and off-pump surgical revascularization of the heart.

Authors:  Lejla Selimović Čeke; Semir Imamović; Farid Ljuca; Zoran Jerkić; Goran Imamović; Munevera Hadžimešić; Aida Pojskić; Jasmina Kovčić
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

7.  Coronary surgery in dialysis-dependent patients with end stage renal failure.

Authors:  S M Tugtekin; K Alexiou; Ch Georgi; U Kappert; M Knaut; K Matschke
Journal:  Z Kardiol       Date:  2005-10

8.  Activation of coagulation and fibrinolysis during coronary artery bypass grafting: a comparison between on-pump and off-pump techniques.

Authors:  Shreosee Roy; Kaushik Saha; Krishnendu Mukherjee; Santanu Dutta; Debasis Mukhopadhyay; Indranil Das; Gargi Raychaudhuri
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

9.  Beating Heart versus Conventional Coronary Bypass Surgery: Our Experience.

Authors:  R Kaushish Retd; M K Unni; M Luthra
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 10.  Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.

Authors:  Masahiro Ide; Daniel Bolliger; Taro Taketomi; Kenichi A Tanaka
Journal:  J Anesth       Date:  2009-12-29       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.